About Epinex Diagnostics
Epinex Diagnostics is a company based in Tustin (United States) founded in 1997. Epinex Diagnostics has raised $4.5 million across 7 funding rounds. The company has 10 employees. Epinex Diagnostics offers products and services including Epinex G1A Test, Epinex ACR Test, and Epinex SimplySure PT-INR Test. Epinex Diagnostics operates in a competitive market with competitors including SD Biosensor, 1Drop Diagnostics, Nova Biomedical, DiabetOmics and BioHermes, among others.
- Headquarter Tustin, United States
- Employees 10
- SectorsHealthcare
- Website epinex.com
- Social LinkedIn X Facebook
- Legal Name Epinex Diagnostics Inc
- Total Equity Funding$4.5M (USD)
in 7 rounds
- Latest Funding Round$100K (USD), Series A
Feb 2016
- Employee Count10
Products & Services of Epinex Diagnostics
Epinex Diagnostics offers a comprehensive portfolio of products and services, including Epinex G1A Test, Epinex ACR Test, and Epinex SimplySure PT-INR Test.
Monthly test for diabetes control and monitoring.
Test for albumin and creatinine ratio in urine.
Test for prothrombin time and blood clotting.
Funding Insights of Epinex Diagnostics
Epinex Diagnostics has successfully raised a total of $4.5M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $100 thousand completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.5M
- Total Rounds 7
- Last Round Series A — $100,000
- First Round $1.17M
(Nov 2009)
All 7 funding rounds of Epinex Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2016 | $100,000 | Series A | – | – | – |
| Jan 2016 | $2.17M | Series A | – | – | – |
| May 2014 | $200,000 | Unspecified | – | – | – |
| Mar 2012 | $50,000 | Unspecified | – | – | – |
| Apr 2011 | $202,756 | Unspecified | – | – | – |
| Aug 2010 | $598,740 | Unspecified | – | – | – |
| Nov 2009 | $1.17M | Unspecified | – | – | – |
People of Epinex Diagnostics
13 people are tracked at Epinex Diagnostics (4 in leadership, 5 in board & advisors, 4 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Azra Zaidi | Director of Research & Development | Leadership |
Asad R. Zaidi | President & CEO | Leadership |
Henry J. Smith | Chief Technology Officer | Leadership |
David Trasoff | Director of Communications | Leadership |
Alan W. Carter | Scientific Advisor | Board & advisors |
Tessa G. Lebinger | Scientific Advisor | Board & advisors |
Omar Ali | Scientific Advisor | Board & advisors |
H. Vernon Roohk | Scientific Advisor | Board & advisors |
David L. Horwitz | Scientific Advisor | Board & advisors |
Salim Aziz | Scientific Advisor | Team |
Pamela Comstock | Scientific Advisor | Team |
Saul Ship | Scientific Advisor | Team |
Rachel Pourcho | Marketing/public Relations Coordinator | Team |
Complete people profiles for Epinex Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Epinex Diagnostics
3 dated milestones of Epinex Diagnostics across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Epinex Diagnostics is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Series A, of $100K.
Competitors of Epinex Diagnostics
Epinex Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, 1Drop Diagnostics, Nova Biomedical, DiabetOmics and BioHermes, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| 1dropdx.com | 2012 | Neuchatel, Switzerland | $7.75M | – | Finger-prick point-of-care diagnostics are provided for biomarker testing. | |
| novabiomedical.com | 1976 | Waltham, United States | – | – | Developer of advanced blood testing analyzers and meters. This company manufactures and sells a wide variety of analyzers for hospital, point-of-care, blood bank, biotechnology, veterinary, and sports medicine applications. Products include blood gas analyzers, glucose meters, lactate meters, and cell culture analyzers. They also offer contract development and manufacturing services for other medical device companies. The analyzers utilize various measurement technologies, including potentiometric, amperometric, and spectrophotometric methods. The company provides complete technical support and product information globally. | |
| diabetomics.com | 2008 | Hillsboro, United States | $11M | 35 | Point-of-care tests for diabetes and women's health risks are developed. | |
| biohermes.com | 2007 | Wuxi, China | – | – | Provider of POC diagnostic devices and kits | |
| dxgenco.com | 2016 | – | – | – | Point-of-care diagnostic products for diabetes and tuberculosis are provided. | |
| ptsdiagnostics.com | 1992 | Indianapolis, United States | – | 211 | Point-of-care diagnostic instruments are developed for disease testing. | |
| labradorhealth.com | 2021 | Tel Aviv, Israel | – | – | Non-invasive testing devices for diabetes prevention are developed. | |
| hemocue.com | 1982 | Angelholm, Sweden | – | – | Point-of-care tests for hematology and diabetes are developed and sold. |
Detailed competitors of Epinex Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Epinex Diagnostics
10 companies that operate in the same segment as Epinex Diagnostics (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Epinex Diagnostics
Epinex Diagnostics was founded in 1997 and raised its 1st funding round 12 years after it was founded.
Epinex Diagnostics is headquartered in Tustin, United States. It is registered at Tustin, California, United States.
Epinex Diagnostics is a funded company, having raised a total of $4.5M across 7 funding rounds to date. The company's 1st funding round was a Unspecified of $1.17M, raised on Nov 2009.
Epinex Diagnostics has 10 employees.
Epinex Diagnostics was founded in 1997 and is based in Tustin, United States. Medical diagnostics products are developed by the company within the healthcare sector. A point-of-care device named G1A is provided for measuring and analyzing glycated albumin graphically. Wireless integration with patient data systems is supported to store test results. An over-the-counter, palm-sized device is also offered for glycated albumin measurement, functioning similarly to glucose meters.
Epinex Diagnostics's top competitors include SD Biosensor, Nova Biomedical and 1Drop Diagnostics.
Epinex Diagnostics offers Epinex G1A Test, Epinex ACR Test, and Epinex SimplySure PT-INR Test.
Epinex Diagnostics operates through Epinex Diagnostics Inc.